Breaking News

Jazz Pharma Begins Work on Manufacturing Site

By Kristin Brooks | February 10, 2014

New facility will be located in Monksland, Ireland

Jazz Pharmaceuticals began construction of a manufacturing and development facility in Monksland, County Roscommon, approximately 75 miles east of the company's Dublin headquarters.
 
"Today marks a milestone for Jazz Pharmaceuticals as we break ground in Ireland and begin, for the first time, construction on a manufacturing and development facility," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals plc. "This investment not only strengthens our international manufacturing capabilities, but importantly represents our commitment to expanding our presence in Ireland.  We are grateful for the partnership of Ireland's Industrial Development Authority (IDA) and Roscommon County Council who helped make this project possible."
 
"Jazz Pharmaceuticals' decision to build a manufacturing site in Ireland is testament to the excellent reputation Ireland has as a global location for biopharmaceutical development and manufacturing," said Mr. Barry O'Leary, chief executive officer IDA Ireland. "This is a strategically important development for Jazz Pharmaceuticals and Ireland is well placed to support manufacturing for the company's growing commercial portfolio."

Related Packaging:

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.

  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?